Compare CVS Health Corp (CVS) vs Dow Jones Industrial Average ETF (DIA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs Dow Jones Industrial Average ETF — how do they compare? CVS Health Corp trades at $86.85 (market cap $112.49B), while Dow Jones Industrial Average ETF trades at $512.92 (market cap $45.20B). The key difference: CVS Health Corp is far larger — about 2.5× Dow Jones Industrial Average ETF's market cap, and CVS Health Corp pays a 3.02% dividend while Dow Jones Industrial Average ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold CVS Health Corp for 83 Days and Dow Jones Industrial Average ETF for 103 Days on average.
| CVS | DIA | |
|---|---|---|
Market Cap | $112.49B | $45.20B |
Volume | 8,467,392 | 4,095,368 |
Sector | Health | — |
52-Week High | $110.60 | $542.79 |
52-Week Low | $70.08 | $451.37 |
Typical Hold Time | 83 Days | 103 Days |
Enterprise Value | $174.83B | — |
Dividend Yield | 3.02% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $87.80, up 1.59% today, with strong analyst support (85% buy ratings) and a $111.20 consensus price target suggesting 27% upside. Recent quarterly earnings have consistently beaten expectations, with Q2 2026 EPS of $2.58 surpassing the $1.87 estimate. Revenue growth remains solid, reaching $402.07B in 2025, though net margins compressed to 1.18%. The technical picture shows bullish momentum with current price near key support at $87.
CVS presents a compelling value opportunity with attractive valuation multiples (P/E 23.21, P/S 0.27) and dividend stability, but faces margin pressure from healthcare cost trends. The stock's upside depends on maintaining earnings momentum amid reimbursement challenges and regulatory scrutiny highlighted in recent legal investigations.
DIA trades at $511.02, down 0.68% with bearish technical signals from moving averages. The ETF shows neutral oscillator readings but faces selling pressure according to ADX indicators. Recent dividend distributions provide income appeal, though key valuation metrics remain unavailable. Support levels cluster around $506-509 while resistance sits at $512-516.
The ETF faces near-term headwinds from technical weakness and broader market volatility. Dividend payments offer income stability, but lack of fundamental metrics limits valuation assessment. Market sentiment remains cautious amid economic uncertainty and Fed policy concerns.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About Dow Jones Industrial Average ETF
The ETF is designed to track the performance of the securities and the stocks in the Dow Jones Industrial Average Index. To maintain the composition and weightings, the advisor adjusts the ETF from time to time to conform to periodic changes in the index target.
Read more on DIA →
